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Doping use in recreational sports is an emerging issue that has received limited attention
so far in the psychological literature. The present study assessed the lifetime prevalence
of controlled performance and appearance enhancing substances (PAES), and used
behavioral reasoning theory to identify the reasons for using and for avoiding using
controlled PAES in young exercisers across five European countries, in the context of
the “SAFE YOU” Project. Participants were 915 young amateur athletes and exercisers
(M = 21.62; SD = 2.62) from Cyprus, Germany, Greece, Italy, and UK who completed
an anonymous questionnaire that included measures of self-reported use of controlled
PAES, as well as reasons for using and not using controlled PAES. The results of the
descriptive analyses demonstrated that almost one out five exercisers in the sample
had a previous experience with controlled PAES. Higher prevalence rates were found
in Greece and Cyprus and lower in Italy. The most frequently reported reasons for
using controlled PAES included achieving the desired results faster; pushing the self
to the (physical) limits; and recovering faster after exercise/training. Furthermore, the
most frequently reported reasons for not using controlled PAES involved worry about
any possible adverse health effects; not feeling the need for using them; and wanting to
see what can be achieved naturally without using any controlled PAES. The findings of
the present study indicate that the use of controlled PAES is fast becoming a crisis in
amateur sports and exercise settings and highlight the need for preventive action and
concerted anti-doping education efforts.
Keywords: doping, behavioral reasoning, exercise, fitness, recreational sport, young adults
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INTRODUCTION
Physical activity and exercise participation have been associated
with a wide range of beneﬁts to mental and physical health
in diverse populations, from healthy young people, to adults
suﬀering from mental illness and elderly people suﬀering from
dementia (de Bruijn et al., 2013; Reiner et al., 2013; Rosenbaum
et al., 2014). Physically active people tend to enjoy a higher
health-related quality of life (Bize et al., 2007), live longer (Arem
et al., 2015), be happier (Wang et al., 2012), and feel more
satisﬁed with their lives (Maher et al., 2015). Furthermore,
physical inactivity is considered to be in the top ﬁve risk factors
for premature morbidity and mortality in developed countries,
and has been associated with major non-communicable diseases,
including diabetes, coronary heart disease, and several types of
cancer (Lee et al., 2012). Scholars and policy-makers have called
for greater promotion of physical activity and exercise globally as
a means to reduce global early morbidity and mortality rates, and
to sustain healthier and more active lifestyles across the lifespan
(Reis et al., 2016).
Nonetheless, the health-enhancing properties of physical
activity and exercise can be oﬀset by certain behaviors, such as the
misuse of performance and appearance enhancement substances
(PAES). In leisure time physical activity and recreational sport
settings, PAES come in two main forms. Uncontrolled PAES
are those substances that can be freely purchased without
any restrictions, and with no legal or social sanctions ensuing
from their use (i.e., protein formulas, creatine, amino-acids,
minerals, and vitamins). On the other hand, controlled PAES
are those substances that their use entails legal sanctions
(i.e., their use is controlled/regulated by law), are deﬁned as
"”doping” substances, and, therefore, are prohibited in elite and
competitive sports according to the rules and regulations of the
World Anti-Doping Agency (WADA), and commonly represent
pharmaceutical compounds and prescribedmedication originally
used to treat diseases. By this deﬁnition, controlled PAES include
hormonal substances like anabolic androgenic steroids (AAS)
and other testosterone derivatives, growth hormone and insulin-
growth factor, erythropoietin, and psychoactive substances like
cannabinoids, stimulants, and opioids (Lazuras and Barkoukis,
2014).
Use of Controlled PAES in Physical
Activity Settings
Whereas the use of controlled PAES is highly regulated by sports
authorities governing competitive sports and has been considered
as a cheating behavior (Morente-Sánchez et al., 2013), the legal
and social sanctions associated with the use of controlled PAES in
ﬁtness and recreational sports are less stringent. For instance, the
2014 UK Steroid Law speciﬁes that the possession and use of AAS
is not an oﬀense (i.e., exercisers who live in the UK can possess
and use AAS). At the same time, the UK Anti-Doping clearly
states that the presence of AAS compounds and other prohibited
PAES or their metabolites in the biological samples of British
competitive and/or elite athletes constitutes an Anti-Doping Rule
Violation (ADRV) and is followed by severe sanctions according
to the WADA anti-doping code. Other countries, like Denmark,
apply more stringent policies against the use of controlled PAES
in both leisure time physical activity and competitive sport
settings (i.e., the same anti-doping laws and sanctions apply
inside and outside main Danish sports organization).
Despite existing policies and regulations, the use of controlled
PAES has become increasingly popular among non-athletes over
the last decade, especially among younger populations. More
speciﬁcally, Pope et al. (2014) estimated that among Americans
aged between 19 and 50 years, about 2.9–4 million people have
used AAS at least once in their lifetime, 22% of users have done
so before the age of 20, and up to 25% of users have experiences
AAS dependence symptoms. Surprisingly, although the non-
medical use of controlled PAES, such as AAS, was conﬁned
among competitive bodybuilders in the 1960s, it has presently
become more common among non-athletes and exercisers with
no athletic ambitions who simply want to improve their physical
appearance and strength (Parkinson and Evans, 2006; Kanayama
et al., 2010). However, the non-medical use of AAS and other
controlled PAES has been associated with a wide range of adverse
mental and physical health symptoms (e.g., depression, anxiety,
mood and body image disturbances, kidney and liver damage,
elevated blood pressure), as well as sudden death (Hartgens
and Kuipers, 2004; Darke et al., 2014; Frati et al., 2015). The
health consequences of controlled PAES use can be even more
pronounced among younger (than older) users (Quaglio et al.,
2009).
Unlike controlled PAES, the use of uncontrolled PAES (e.g.,
dietary supplements) has not been extensively associated with
adverse and potentially lethal symptoms, except in the case of
certain products that were later considered controlled PAES (e.g.,
ephedrine) or products being contaminated with AAS and other
toxic compounds (Geyer et al., 2008; Kohler et al., 2010). Current
evidence shows that using dietary supplements is associated with
future use of AAS in both adolescent and young adults in physical
activity and sports settings (Dodge and Jaccard, 2006; Ntoumanis
et al., 2014).
Behavioral Reasoning Theory and PAES
Use
A large body of research has shown that the use of controlled
PAES in competitive and elite sport settings is rather as goal-
directed and intentional (Lucidi et al., 2008; Lazuras et al., 2015).
Albeit manifested in a diﬀerent (and possibly less competitive)
context, the use of controlled PAES in physical activity and
exercise settings can also be seen as goal-directed (Allahverdipour
et al., 2012; Petróczi, 2013; Ntoumanis et al., 2014). Theories of
intention-formation and decision-making processes can help us
better understand how athletes and/or exercisers decide to use
controlled PAES (Lazuras, 2015). Behavioral reasoning theory is
a relatively new model of human decision-making and behavior
that aims to better understand the link between beliefs, intentions
and behavior by addressing the reasons why people engage (or
avoid engaging) in certain behaviors (Westaby, 2005). According
to this theory, context-speciﬁc reasons play a key role in the
intention-formation and behavior-initiation process, and that a
better understanding of reasons can elucidate how behavior-
speciﬁc beliefs (e.g., attitudes) are formed (Westaby et al.,
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2010). Applying the behavioral reasoning theory in the context
of PAES use in exercise and ﬁtness settings can signiﬁcantly
extend the existing knowledge base by revealing the multitude
of reasons exercisers decide to use (or to abstain from using)
PAES (Petróczi et al., 2017). While a lot of research on controlled
PAES has focused on intention-formation theories, such as the
theory of reasoned action and the theory of planned behavior
(Ntoumanis et al., 2014), a single study applied behavioral
reasoning in the context of doping use in elite sports (Overbye
et al., 2013), but no study has addressed the role of context-
behavioral reasons in the context of controlled PAES use in
exercise.
The Present Study
Millions of young people engage in physical activity and
exercise globally, and there are calls for eﬀorts to further
increase the number of people engaging in physical activity
in the near future as this is expected to yield greater
public health beneﬁts, and to reduce early lifestyle-related
morbidity and mortality (Lee et al., 2012; Reis et al., 2016).
However, the beneﬁts of physical activity can be countered
by the use and/or misuse of controlled PAES and the
ensuing adverse health eﬀects, especially among younger people
(Quaglio et al., 2009). Considering the number of young
people currently engaging in physical activity, as well as the
projected number of young people who will be exercising
in the future, it is of paramount importance to safeguard
physical activity and exercise from potentially unhealthy and
unsafe practices such as the use of controlled PAES. Doing
so requires a better understanding of PAES use patterns
and prevalence among young exercisers at an international
scale, as well as a better understanding of the reasons
why some exercisers decide to engage (or avoid engaging)
in the use of controlled PAES. Studying such reasons can
further elucidate the underlying decision-making and intention-
formation process in the speciﬁc context (Westaby, 2005)
and inform future anti-doping campaigns. So far, there has
been a relative paucity of research on the prevalence of
controlled PAES among young exercisers, and the existing
studies have focused on single countries. Therefore, a more
comprehensive and international perspective on the use of
controlled and uncontrolled PAES is warranted. Accordingly,
no studies have assessed the behavioral reasons for using and
not using controlled PAES among recreational sport participants
thus far.
The present study assessed the lifetime prevalence of
controlled PAES, as well as the reasons for using and for avoiding
using controlled PAES in a large sample of young exercisers
across ﬁve European countries. The study reported here is
part of a larger-scale, European-wide research project (Project
SAFE YOU1) and was concerned with research and education
against doping use among young people in exercise settings.
Below, we report ﬁndings about the prevalence of controlled and
uncontrolled PAES use, demographic characteristics of users, as
well as reasons for using and for avoiding PAES use.
1http://safeyou.eu/
MATERIALS AND METHODS
Sample
A total of 915 exercisers participated in the study with an age
range between 16 and 25 years old (M = 21.62; SD = 2.62;
males = 584, females = 315; 16 participants preferred not to
say or did not report their gender). Participants were recruited
from ﬁve European countries namely Cyprus, Germany, Greece,
Italy, and the UK (see Table 1 for information on the participants
in each country). An analysis of variance (ANOVA) indicated
that German participants were signiﬁcantly older and UK
participants were signiﬁcantly younger than participants from
Cyprus, Greece, and Italy, F(4,914) = 135.03, p < 0.001.
Participants were randomly selected and invited to take part
in the study either in the gum or through online advertising
of the study. Eligible participants should exercise systematically
(i.e., 2–3 times per week). The participants were recreational
exercisers and amateur athletes mainly involved in ﬁtness,
amateur weightlifting, and bodybuilding, as well as team sport
(e.g., soccer and basketball).
Participants had an average of 8.85 (SD = 9.06) years of
sport participation experience. An ANOVA indicated that Italian
and German participants reported signiﬁcantly more years of
experience as compared to Greek and Cypriot participants,
F(4,891) = 22.92, p < 0.001. In Cyprus and Greece the
participants were mainly gym users and exercisers involved in
ﬁtness, non-competitive body-building, martial arts and running,
and gym/ﬁtness users comprised the sample from Germany.
Participants in Italy were university students in sport sciences
who involved in physical activity and exercise programs. Finally,
the participants in the UK sample were senior high school and
university students who regularly engaged in physical activity and
exercise.
Measures
A structured and anonymous questionnaire was used that
includedmeasures of self-reported use of controlled PAES, as well
as reasons for using and not using controlled PAES.
Use of Controlled PAES
To ensure that all participants had the same understanding
of controlled PAES, the following deﬁnition was given at the
beginning of the questionnaire: “Controlled PAES refer to those
substances that are used to build muscles, lose weight and
generally enhance the athletic performance but are controlled by
the government and/or a sport governing body such as the WADA
because they can cause harm. Examples of controlled PAES include
anabolic steroids, growth hormones, EPO, stimulants, substances
that increase blood ﬂow or open airways. With this deﬁnition, we
do not include any kind of dietary supplements (e.g., vitamins,
proteins, and minerals) that are used to enhance nutrition intake
and are not controlled and are available to anyone without
restrictions.” The use of controlled PAES was measured with a
single question ‘Which one of the following statements regarding
PAES use describes you the best?’ followed by ﬁve response
options; 1 (= I currently use PAES and people who are important
to me know about it), 2 ( = I currently use PAES but people who
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TABLE 1 | Participant’s characteristics in each country.
N M age SD N males N females M years of
experience
SD
Cyprus 152 22.13 2.62 107 45 6.33 3.23
Germany 187 (1) 23.11 1.83 99 85 9.86 5.80
Greece 199 21.87 2.74 154 45 5.86 4.05
Italy 218 (4) 22.20 1.56 128 86 13.13 15.80
UK 159 (9) 18.25 2.02 96 54 8.07 4.47
are important to me don’t know about it), 3 ( = I used PAES in
the past but I do not use now and people who are important to
me knew about it), 4 ( = I used PAES in the past but I do not
use now and people who are important to me didn’t know about
it), and 5 ( = I never used PAES). Participants who marked the
ﬁfth option were deemed as lifetime non-users of controlled PAES,
whereas those marking any of the other response options (i.e.,
self-reporting controlled PAES use) were deemed lifetime users of
controlled PAES.
Reasons for Using PAES
Participants who self-reported the use of controlled PAES were
further asked to complete a questionnaire denoting their reasons
for doing so. The items of this questionnaire were generated by
the researchers based on the proposed utility of such approach
(Petróczi et al., 2017); as well as informal discussions with PAES
users and previous literature (Lentillon-Kaestner and Carstairs,
2010; Overbye et al., 2013). The response options included 10
reasons for PAES use (example items ‘it helps to achieve my
performance or appearance-related goals,’ and ‘it helps to achieve
my desired results faster’). Responses were anchored on a 6-point
Likert-type scale ranging from 1 (not true for me at all) to 6
(very true for me). Cronbach’s α coeﬃcient indicated high and
satisfactory internal consistency (α = 0.96).
Reasons for Not Using PAES
Participants who did not self-report the use of controlled PAES
were asked to complete a questionnaire about their reasons
for their abstinence. Similarly to the Reasons for Using PAES
questionnaire, the items were generated based on informal
discussions with non-users and past research (Lentillon-Kaestner
and Carstairs, 2010; Overbye et al., 2013). The response options
comprised 12 items (example items: ‘I worry about possible side
eﬀects on my health’ and ‘People whose opinion is important to
me do not want me to use it’). Participants responded on a 6-
point Likert-type scale ranging from 1 (not true for me at all) to 6
(very true for me). The internal consistency of the scale was high
(Cronbach’s α = 0.87).
Procedure
The study obtained approval by the Faculty Research Ethics
Committee, Faculty of Science, Engineering and Computing,
Kingston University London. Sport gyms, recreational clubs,
student unions, and schools were approached and the aim
of the study was described. The collection of the data run
in all participating countries: Cyprus, Germany, Greece,
Italy, and the UK. The surveys were completed online (in
Italy and the UK, part of the sample in Germany) or face-
to-face with printed questionnaires (in Cyprus, Greece,
and part of the sample in Germany). In the face-to face
condition participants completed the surveys alone under
the supervision of trained personnel. Completion lasted
approximately 20 min. In line with the code of human research
ethics of the British Psychological Society, all participants
were duly informed about the aims and purposes of the study,
provided implied informed consent by voluntary participation,
were informed about their participations rights (i.e., voluntary
participation, termination of participation at any time without
prior notice and negative consequences), and were reassured
about the anonymity and conﬁdentiality of their data. For
participants younger than 18 years old parental consent was
also obtained. The survey was anonymous and participants were
re-assured that the surveys will be used for research purposes
solely.
Data Analysis
Statistical analyses were performed with the use of SPSS 22.0.
Descriptive statistics were used to estimate the prevalence of
controlled PAES use. Diﬀerences among the countries in reasons
for using or for abstaining from controlled PAES’ use were tested
with ANOVA.
RESULTS
Lifetime Prevalence of Controlled PAES
Use
The prevalence of controlled PAES use for the total sample in
each country is reported inTable 2. Overall, the analysis indicated
that 19.3% of the total sample of participants had some experience
with PAES use at least once in their lifetime, either in the past or
in the present (i.e., 80.7% declared that they never used controlled
PAES). A chi-square test of independence was performed to
examine the relation between country and PAES use. The relation
between these variables was signiﬁcant,χ2 (16,N = 908)= 62.85,
p < 0.001. Higher prevalence rates were reported for Cyprus
(28.9%) and Greece (27.6%) where participants were gym users
and exercisers, whereas lower rates were found in the Italian
sample (11.5%) that comprised by university students. In all
countries except Greece, the majority of participants who self-
reported controlled PAES use also said that people who were
important to them knew about it.
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TABLE 2 | Self-reported use of controlled PAES in five European countries.
Total sample Cyprus Germany Greece Italy UK
N (%) N (%) N (%) N (%) N (%) N (%)
I currently use PAES and people who are important to me
know about it
65 (7.2) 21 (13.8) 14 (7.7) 15 (7.5) 4 (1.8) 11 (7.0)
I currently use PAES but people who are important to me
don’t know about it
20 (2.2) 3 (2.0) 2 (1.1) 11 (5.5) 1 (0.5) 3 (1.9)
I used PAES in the past but I do not use now and people
who are important to me knew about it
49 (5.4) 13 (8.6) 7 (3.8) 8 (4.0) 13 (6.0) 8 (5.1)
I used PAES in the past but I do not use now and people
who are important to me didn’t know about it
44 (4.8) 7 (4.6) 8 (4.4) 21 (10.6) 7 (3.2) 1 (0.6)
I never used PAES 730 (80.4) 108 (71.1) 151 (83.0) 144 (72.4) 193 (88.5) 134 (85.4)
TABLE 3 | Self-reported reasons for using controlled PAES in five European countries.
Total
sample
Cyprus Germany Greece Italy UK
It helps me achieve my performance or appearance-related goals 37.0 40.7 0.0 34.6 41.2 36.4
I follow a recommendation of someone whose opinion is important to me 30.8 30.8 20.2 37.3 23.5 18.2
It helps me achieve my desired results faster 40.1 40.7 55.6 38.5 29.4 31.8
I want to see how far I can push my physical limits 40.4 40.1 29.4 53.9 35.3 38.1
I follow what most people around me are doing 20.7 18.4 41.2 38.5 17.6 27.3
It helps to recover faster after exercise/training 40.5 39.5 35.3 48.1 52.9 45.5
It helps to aid recovery after injury 30.2 47.4 29.4 36.5 35.3 19.0
I want to get advantage in competition 30.6 47.3 11.8 36.5 23.5 27.2
It is a normal part of any serious exercise/training regime 38.4 50.0 29.4 40.4 29.4 31.8
I’m curious to find out if it really works 30.9 36.8 37.5 42.3 41.2 33.3
The values shown in each column represent the percentage of participants who scored on the extreme ends of the measurement scale (i.e., 5 = true for me and 6 = very
true for me).
Reasons for Using Controlled PAES
Analysis of variance was used to assess the diﬀerences between
countries in the mean scores of reasons for using controlled
PAES. Accordingly, analysis of frequencies was used to indicate
the most common reasons for using controlled PAES. The results
showed that there were non-signiﬁcant diﬀerences between
countries, F(4,147) = 1.84, p = 0.123. Furthermore, frequency
analysis in the total sample showed that the three most important
reasons for using controlled PAES included: achieving the
desired results faster; pushing the self to the (physical) limits;
and recovering faster after exercise/training. Following what
most people are doing was the less frequently reason reported
(Table 3).
However, each country seemed to have a diﬀerent proﬁle with
respect to the reasons that emerged for using controlled PAES.
More speciﬁcally, in Cyprus participants reported recovery after
injury, having advantage in competition, and being a normal
part of any serious exercise/training regime as the most common
reasons for using controlled PAES. On the other hand, following
what most people is doing was the less frequently reason
reported by the Cypriot participants. In Germany, achieving the
desired results faster, following what most people are doing,
and curiosity about the eﬀects of PAES on performance and
physical appearance were the most frequently reported reasons
for using controlled PAES, whereas achieving performance or
appearance-related goals was the least frequently reported. Greek
exercisers reported pushing their physical limits, recovering faster
after exercise/training, and curiosity as the reasons that better
described their PAES use, whereas achieving performance or
appearance-related goals was the least frequently reported one.
In Italy, achieving performance or appearance-related goals,
recovering faster after exercise/training, and curiosity were the
most frequently reported reasons for PAES use, whilst following
what most people is doing was the least frequently reported
reason. Finally, in the UK, the most commonly reported reasons
for using controlled PAES included achieving performance or
appearance-related goals, pushing physical limits, and recovering
faster after exercise/training, and following recommendations
from important others was the least frequently reported one.
Reasons for Avoiding Using Controlled
PAES
Analysis of variance was also used to assess for between-
country diﬀerences in the reasons for abstaining from the use
of controlled PAES. The results showed that there were non-
signiﬁcant diﬀerences in the mean scores between countries,
F(4,575) = 1.15, p = 0.318. Analysis of frequencies further
showed that, in the total sample, the most commonly reported
reasons for not using controlled PAES included: worry about any
possible adverse health eﬀects; not feeling the need for using
them; and wanting to see what can be achieved naturally without
using any controlled PAES. The least frequently reported reason
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TABLE 4 | Self-reported reasons for not using controlled PAES in five European countries.
Total
sample
Cyprus Germany Greece Italy UK
I worry about possible side effects on my health 71.6 82.1 85.9 44.9 78.7 60.2
I lack trust in the quality and ingredients 63.4 76.9 73.9 48.3 61.5 60.3
I do not feel the need for it 75.9 84.6 88.7 55.7 80.0 66.7
People whose opinion is important to me do not want me to use it 48.7 60.0 50.0 44.9 48.9 45.7
I worry about the legal consequences 43.2 43.6 48.6 37.1 39.6 47.4
I want to see what I can do naturally 72.6 65.0 74.6 57.3 79.4 73.9
Not many people around me using it 45.8 27.0 47.5 36.0 50.0 50.1
I cannot afford it 24.1 41.0 19.9 38.6 13.8 28.7
If I use PAES, it is no longer 100% me 68.3 65.9 70.9 58.4 74.0 64.3
I do not know where to buy it 30.6 27.3 32.9 31.5 22.1 41.7
It would give me unfair advantage in a competition 63.8 55.8 73.0 44.9 69.6 60.7
I do not know what to take and how to take it 36.6 23.3 34.5 38.2 35.6 46.0
The values shown in each column represent the percentage of participants who scored on the extreme ends of the measurement scale (i.e., 5 = true for me and 6 = very
true for me).
was not being able to aﬀord buying controlled PAES. The results
from the frequency analysis concerning the reasons for abstaining
from PAES use are reported in Table 4.
In each country, diﬀerent reasons emerged as most and least
important for abstaining from PAES use. More speciﬁcally, in
Cyprus, the most commonly reported reason for not using PAES
included worry about possible health side eﬀects; not feeling
the need for it; and lack of trust in the quality and ingredients
of controlled PAES use. The least frequently reported reason
was the belief that the majority of people around (i.e., other
exercisers) were not using controlled PAES. In Germany and
Italy, the most common reasons for not using PAES included
worry about possible health side eﬀects, not feeling the need
for it, and wanting to see what can be achieved naturally
without using controlled PAES. Also, German participants
reported not being able to aﬀord buying PAES as the least
reported reason, whereas not having access to PAES was the
least frequently reported reason in Italy. In Greece and the UK,
not feeling the need for it, a not being “100% me” approach,
and wanting to see what can be achieved naturally were the
most commonly reported reasons for not using controlled
PAES. Not having access to PAES and not being able to
aﬀord it were the least reported reasons in both Greece and
the UK.
DISCUSSION
The present study assessed the self-reported use of controlled
PAES, as well as the reasons for using and for abstaining
from PAES use in a large sample of young people involved
in exercise and amateur sports across ﬁve European countries:
Cyprus, Germany, Greece, Italy, and the UK. The results
showed that, overall, 19.3% of participants appear to have
some sort of experience with the use of controlled PAES,
either in the past or in the present. Given that self-reported
measures of controlled PAES use may be susceptible to under-
reporting biases (Gucciardi et al., 2010; Petróczi et al., 2010;
de Hon et al., 2015), the prevalence of PAES use found in
the present paper may actually be an underestimation of the
actual prevalence of controlled PAES use among young exercisers
in the countries we examined. Furthermore, our ﬁndings also
showed that relatively higher use of controlled PAES was self-
reported in Cyprus, Greece, and Germany where participants
were mostly gym users and ﬁtness exercisers, than in Italy and
UK who were mostly high school and university students. These
ﬁndings suggest that almost one out of ﬁve young exercisers
in the overall, European-wide sample that was used in the
present study admitted the use of controlled PAES. Importantly,
controlled PAES use reﬂects the misuse of mostly pharmaceutical
compounds and prescribed medication, without any medical
cause and with the sole motive to enhance physical appearance
and athletic performance in physical activity settings. Controlled
PAES use has been associated with a wide range of adverse
mental and physical health eﬀects, as well as early and sudden
death in certain occasions (e.g., Quaglio et al., 2009; Darke
et al., 2014; Frati et al., 2015). Apparently, using controlled
PAES represents an unsafe practice that can oﬀset the health
beneﬁts of physical activity and exercise. Given the current
numbers of young people presently involved in exercise and
physical activity, as well as the projected number of young
exercisers in the next decade, it seems that the use of controlled
PAES is an emerging public health concern that merits the
attention of both policy-makers and researchers involved in
the promotion of physical activity and its health-enhancing
properties.
Following from the study by Overbye et al. (2013) about
reasons for doping use in elite athletes, our research was the
ﬁrst one to apply concepts from behavioral reasoning theory
(Westaby, 2005) to the study of controlled PAES use in an
international sample of young exercisers. Interesting ﬁndings
emerged with respect to the reasons for both using and avoiding
using controlled PAES. Overall, it appears that controlled PAES
use in the present sample was motivated mostly by the need to
achieve the desired goals, whether this is relevant to enhancing
athletic performance, improving physical appearance, or both.
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These ﬁndings attest to the goal-directedness of controlled
PAES use among young exercisers. The ﬁndings also indicate
that, albeit most of our participants were exercisers and non-
competitive amateur athletes, those who self-reported the use
controlled PAES appear to have a “competitive sports’ mindset
by being focused too much on improving performance, reaching
goals and recovering from training, than enjoying the health
beneﬁts of exercise. Curiosity also emerged as a commonly
reported reason for using controlled PAES in Italy, Greece, and
Germany but not as much in the UK and Cyprus. This ﬁnding
suggests that preventive action against the use of controlled
PAES in exercise settings may beneﬁt by shifting the focus
from immediate performance enhancement eﬀects and raising
exercisers’ awareness about the actual and long-term eﬀects of
controlled PAES use on their mind and body. Similar studies
in the context of competitive sports have shown that elite
athlete tend to downplay the long-term and harmful eﬀects
of doping use on their health by focusing on the immediate
eﬀects of doping in performance improvement (e.g., Lentillon-
Kaestner et al., 2012). A similar process may be in place in
PAES use in amateur and ﬁtness sports, and future studies
should further look into risk perception of PAES use in this
context.
More speciﬁcally, worry about the health eﬀects of controlled
PAES use was among the most commonly reported reasons for
not using such substances. Other frequently reported abstinence
reasons included not feeling the need to use controlled PAES as
well as a determination to enjoy exercise and anticipate beneﬁts
without using PAES. Possibly, there may be a mentality aspect
there with some exercisers being committed to more “natural”
and drug-free exercise styles, but this is a tentative argument that
requires further empirical investigation. According to behavioral
reasoning theory, reasons for and against the use of controlled
PAES, may independently predict attitudes and intentions to
use PAES (Petróczi et al., 2017). In line with this argument,
our ﬁndings indicate that reasons for using and for abstaining
using controlled PAES diﬀerentiate, with the former depicting
high achievement motives and a “competitive” mindset, and the
latter representing more “natural exercising” motives. Future
research may indicate whether this diﬀerentiation is reﬂected in
diﬀerential attitudes and intentions toward using (and not using)
controlled PAES, respectively.
Finally, in Greece and the UK the reasons for not using
controlled PAES depicted identity concerns (e.g., “If I use PAES,
it is no longer 100% me”), and this indicates that self-identity
and/or self-categorization processes may be relevant to the ways
exercisers reason and decide to act with respect to the use of
controlled PAES. Rees et al. (2015) recently argued that a social
identity approach can broadly beneﬁt research on sport and
exercise psychology issues. Nevertheless, no study so far has
addressed social identity and/or self-categorization in the context
of controlled PAES use either in competitive/elite sports or in
exercise/amateur sports settings.
Furthermore, our ﬁndings can also be explained in the
context of other theoretical approaches than behavioral reasoning
theory. More speciﬁcally, the seeming urgency for immediate
performance improvement (e.g., achieving desired results and/or
recovering from injury faster) that surfaced in our analysis of
the reasons for using PAES indicates that impulsivity/urgency
and self-regulation failure may partly explain the psychological
process underlying PAES use in amateur and ﬁtness sports.
Perhaps the application of self-regulation theory, such asMetcalfe
and Mischel’s (1999) analysis of self-regulation failure and
delayed gratiﬁcation, may add further to our understanding
of PAES use in this population. Incorporating self-regulatory
capacities in the study of PAES use in amateur sports will also
further extend existing social cognitive models of doping use in
competitive sports (e.g., Chan et al., 2015).
Overall, the present study showed that roughly one out of
ﬁve young exercisers self-reported the use of controlled PAES
Preventive action is needed in order to control the use of
PAES in physical activity and exercise settings; otherwise, the
health-enhancing properties of exercising may be compromised.
Furthermore, a competitive “mindset” appears to dominate the
reasons for using controlled PAES, with a strong emphasis on
improving performance and achieving results faster. On the
contrary, worry about adverse health eﬀects and a commitment to
being natural and unaﬀected by PAES use dominated the reasons
for abstaining from controlled PAES use. While providing
insightful ﬁndings about PAES use in amateur and ﬁtness sports,
our study was not free of limitations. In particular, our ﬁndings
relied on self-reports and, therefore, may be inﬂuenced by
reporting bias and social desirability (Gucciardi et al., 2010).
Therefore, the prevalence rates we report in this paper may
actually underestimate the actual prevalence of controlled PAES
in our population. Secondly, we did not account for the co-
occurrence of controlled and uncontrolled PAES (e.g., nutritional
supplements). This would allow us to provide more detailed
analysis of PAES use patterns, by identifying exercisers/amateur
athletes that were non-users, those who used only uncontrolled
PAES (e.g., nutritional supplements), and those who used both
nutritional supplements and controlled PAES, or only controlled
PAES. Such an analysis would be meaningful to identify if users
of nutritional supplements display similar motivational patterns
with PAES users with respect to the reasons for using (or avoiding
the use of) controlled PAES. Past research has shown that
users of nutritional supplements tend to view doping substances
more favorably than non-users of supplements (Barkoukis et al.,
2015). Future research may further address those limitations
and provide further insights into the psychological processes
underlying PAES use in amateur and recreational sports.
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